NanoViricides, Inc.
NanoViricides, Inc., a nano-biopharmaceutical company, discovers, develops, and commercializes drugs for the treatment of viral infections. Its products pipeline includes HerpeCide Dermal Topical and Eye Drops for the treatment of shingles, PHN, chickenpox, herpes, recurrent herpes labialis, genital herpes, and ocular herpes keratitis; and HerpeCide IntraOcular Injection for viral acute retinal necrosis. The company also develops FluCide Broad-Spectrum Anti-Influenza nanoviricide, which is injectable for hospitalized patients and oral for outpatients; Nanoviricide eye drops for viral diseases of the external eye; DengueCide for treatment of all types of Dengue viruses; and HIVCide that is an escape-resistant anti-HIV nanoviricide. In addition, it is also involved in research and development of other nanoviricides drug projects for treatment of different viruses and indications; and HerpeCide program expansion drug projects for different herpes viruses for different indications. NanoViricides, Inc. was founded in 2005 and is based in Shelton, Connecticut. Show More...
-
Website http://www.nanoviricides.com
-
Sector Healthcare
-
Industry Biotechnology
-
Last Quote 1.52 USD
-
Last Updated 30-05-2025
-
External Links Yahoo Finance Morningstar Ratios
-
Interest Coverage
The interest coverage ratio is a debt ratio and profitability ratio used to determine how easily a company can pay interest on its outstanding debt.
Reference: Investopedia -
2010-06 2011-06 2012-06 2013-06 2014-06 2015-06 2016-06 2017-06 2018-06 2019-06 TTM Earnings Per Share USD -2.8 -3.2 -3.0 -3.8 -5.4 -1.8 -3.8 -3.4 -2.6 -2.4 -2.13 Dividends USD Payout Ratio % * Shares Mil 2.0 2.0 2.0 2.0 3.0 3.0 3.0 3.0 3.0 4.0 4.0 Book Value Per Share * USD 3.41 4.96 6.1 4.3 11.73 11.13 8.24 7.08 5.53 3.31 0.85 Free Cash Flow Per Share * USD -1.5 -2.36 -2.03 -2.35 -4.23 -4.53 -2.86 -2.87 -1.75 -2.5 Return on Assets % -79.11 -65.59 -47.05 -55.41 -46.27 -4.95 -26.54 -32.39 -37.6 -52.66 -58.9 Financial Leverage (Average) 1.38 1.06 1.13 2.05 1.56 1.39 1.59 1.32 1.05 1.27 1.5 Return on Equity % -105.47 -77.69 -51.72 -81.25 -77.07 -7.28 -39.12 -47.53 -45.1 -59.63 -72.74 Return on Invested Capital % -105.47 -77.87 -52.11 -54.47 -43.23 3.83 -21.86 -31.2 -42.76 -60.02 -66.38 Interest Coverage -7.13 -2.85 0.43 -3.34 -3.84 -14.73 Current Ratio 3.01 16.27 8.2 12.33 30.7 52.73 3.62 3.28 8.3 0.99 0.35 Quick Ratio 2.81 15.71 8.02 11.82 29.91 52.37 3.58 3.24 8.03 0.9 0.18 Debt/Equity 0.43 0.32 0.23 0.14